Irisin alleviates palmitic acid-induced osteogenic inhibition in bone marrow mesenchymal stem cells

doi:10.12307/2023.772

Abstract

Abstract: BACKGROUND: Irisin, a myokine isolated from the transmembrane protein FNDC5 by muscle cells during exercise, has the function of inducing the browning of white adipose tissue, but its effect on lipotoxicity-induced osteogenic differentiation and the mechanism is unclear.
OBJECTIVE: To investigate the effect of irisin on the osteogenic ability of palmitic acid-induced bone marrow mesenchymal stem cells and the mechanism of action.
METHODS: CCK-8 assay was used to detect the effect of different concentrations of palmitic acid on the proliferation of mouse bone marrow mesenchymal stem cells and the effect of irisin on the proliferation of mouse bone marrow mesenchymal stem cells in the presence of palmitic acid. After pretreatment with irisin and palmitic acid for 24 hours, osteogenic differentiation of mouse bone marrow mesenchymal stem cells was induced by alkaline phosphatase staining as well as qRT-PCR was performed to detect the expression of osteogenesis-related genes on day 7 of osteogenic induction culture. The expression of proteins related to the AMPK/BMP2/SMAD signaling pathway was detected by western blot assay. Alizarin red staining was conducted on day 21 to detect osteogenic differences.
RESULTS AND CONCLUSION: (1) The CCK-8 assay results suggested that the amplification of bone marrow mesenchymal stem cells was inversely proportional to the concentration of palmitic acid, but at 0.02 mmol/L concentration, palmitic acid had no significant effect on the amplification of bone marrow mesenchymal stem cells, and irisin did not affect the proliferation of bone marrow mesenchymal stem cells when its mass concentration was in the range of 0.1-20 μg/L. (2) Alkaline phosphatase staining and alizarin red staining showed that palmitic acid inhibited the osteogenic differentiation ability of bone marrow mesenchymal stem cells. Irisin improved palmitic acid-induced osteogenic inhibition of bone marrow mesenchymal stem cells. qRT-PCR results showed that palmitic acid could cause the downregulation of osteogenic-related genes, and irisin could inhibit this trend. (3) Western blot assay results showed that compared with the palmitic acid intervention group, irisin treatment enhanced AMPK/BMP2/SMAD signal transduction in bone marrow mesenchymal stem cells. It is found that irisin can improve the osteogenic differentiation ability of bone marrow mesenchymal stem cells pretreated with palmitic acid, and proposed that the specific mechanism might be mediated by AMPK/BMP/SMAD signaling pathway.

Key words: bone marrow mesenchymal stem cell, irisin, palmitic acid, osteogenic differentiation, AMPK/BMP2/SMAD pathway

CLC Number:

Zhang Yuanshu, He Xu, Xue Yuan, Jin Yesheng, Wang Kai, Shi Qin, Rui Yongjun. Irisin alleviates palmitic acid-induced osteogenic inhibition in bone marrow mesenchymal stem cells[J]. Chinese Journal of Tissue Engineering Research, 2024, 28(1): 26-31.

Figures/Tables 6

References

[1] RINONAPOLI G, PACE V, RUGGIERO C, et al. Obesity and Bone: A Complex Relationship. Int J Mol Sci. 2021;22(24):13662.
[2] HANNAN MT, FELSON DT, ANDERSON JJ. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res. 1992;7(5):547-553.
[3] EDELSTEIN SL, BARRETT-CONNOR E. Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol. 1993;138(3):160-169.
[4] HU FB. Overweight and obesity in women: health risks and consequences. J Womens Health (Larchmt). 2003;12(2):163-172.
[5] Obesity: preventing and managing the global epidemic. Report of a WHO consultation.World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
[6] WOSJE KS, KHOURY PR, CLAYTOR RP, et al. Adiposity and TV viewing are related to less bone accrual in young children. J Pediatr. 2009;154(1): 79-85.e2.
[7] DEFRONZO RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53(7):1270-1287.
[8] SAMUEL VT, PETERSEN KF, SHULMAN GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375(9733):2267-2277.
[9] LI L, GU Z, ZHANG J, et al. CTRP9 overexpression attenuates palmitic acid-induced inflammation, apoptosis and impaired migration in HTR8/SVneo cells through AMPK/SREBP1c signaling. Exp Ther Med. 2022;24(1):459.
[10] ÁVALOS Y, HERNÁNDEZ-CÁCERES MP, LAGOS P, et al. Palmitic acid control of ciliogenesis modulates insulin signaling in hypothalamic neurons through an autophagy-dependent mechanism. Cell Death Dis. 2022;13(7):659.
[11] DESIDERIO V, TIRINO V, PAPACCIO G, et al. Bone defects: molecular and cellular therapeutic targets. Int J Biochem Cell Biol. 2014;51:75-78.
[12] GRANERO-MOLTO F, WEIS JA, LONGOBARDI L, et al. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther. 2008;8(3):255-268.
[13] GIMBLE JM. The function of adipocytes in the bone marrow stroma. New Biol. 1990;2(4):304-312.
[14] PITTENGER MF, MACKAY AM, BECK SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
[15] TENCEROVA M, KASSEM M. The Bone Marrow-Derived Stromal Cells: Commitment and Regulation of Adipogenesis. Front Endocrinol (Lausanne). 2016;7:127.
[16] ABDALLAH BM, KASSEM M. New factors controlling the balance between osteoblastogenesis and adipogenesis. Bone. 2012;50(2):540-545.
[17] JAFARI A, QANIE D, ANDERSEN TL, et al. Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis. Stem Cell Reports. 2017;8(2): 373-386.
[18] BOSTRÖM P, WU J, JEDRYCHOWSKI MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 20121;481(7382):463-468.
[19] XIONG XQ, GENG Z, ZHOU B, et al. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018;83:31-41.
[20] MURUGANANDAN S, SINAL CJ. The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation. IUBMB Life. 2014;66(3): 147-155.
[21] MAAK S, NORHEIM F, DREVON CA, et al. Progress and Challenges in the Biology of FNDC5 and Irisin. Endocr Rev. 2021;42(4):436-456.
[22] KIM H, WRANN CD, JEDRYCHOWSKI M, et al. Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. Cell. 2018;175(7):1756-1768.e17.
[23] HU S, XUE Y, HE J, et al. Irisin recouples osteogenesis and osteoclastogenesis to protect wear-particle-induced osteolysis by suppressing oxidative stress and RANKL production. Biomater Sci. 2021;9(17):5791-5801.
[24] COLAIANNI G, CUSCITO C, MONGELLI T, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A. 2015;112(39): 12157-12162.
[25] QIAO X, NIE Y, MA Y, et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016;6:18732.
[26] LUO Y, MA Y, QIAO X, et al. Irisin ameliorates bone loss in ovariectomized mice. Climacteric. 2020;23(5):496-504.
[27] ZHANG Y, LI R, MENG Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63(2):514-525.
[28] MURUGANANDAN S, GOVINDARAJAN R, SINAL CJ. Bone Marrow Adipose Tissue and Skeletal Health. Curr Osteoporos Rep. 2018;16(4): 434-442.
[29] LI J, CHEN X, LU L, et al. The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis. Cytokine Growth Factor Rev. 2020;52:88-98.
[30] YE W, WANG J, LIN D, et al. The immunomodulatory role of irisin on osteogenesis via AMPK-mediated macrophage polarization. Int J Biol Macromol. 2020;146:25-35.
[31] XUE Y, HU S, CHEN C, et al. Myokine Irisin promotes osteogenesis by activating BMP/SMAD signaling via αV integrin and regulates bone mass in mice. Int J Biol Sci. 2022;18(2):572-584.